James F. Cummings - Mar 28, 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role: Chief Medical Officer
Signature: /s/ Andrei Floroiu, Attorney-in-Fact for James Cummings
Stock symbol: VXRT
Transactions as of: Mar 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/30/2022, 09:24 PM
Previous filing: Oct 7, 2021
Next filing: Mar 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VXRT	Common Stock	Award	$0	+43.8K		$0.00	43.8K	Mar 28, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VXRT	Stock Option (right to buy)	Award	$0	+263K		$0.00	263K	Mar 28, 2022	Common Stock	263K	$5.09	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the fourth anniversary of the grant date.
F2	The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 28, 2023, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 28, 2026.